Last updated on April 2019

A Multi-Center Randomized Double-Masked Parallel-Group Vehicle-Controlled Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

Brief description of study

A Multi-Center, Phase 2, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution (0.25% Novel Formulation) Compared to Vehicle in Subjects with Dry Eye Disease

Clinical Study Identifier: NCT03916042

Find a site near you

Start Over

Andover Eye Associates

Andover, MA United States
  Connect »